An Unusual Intramolecular Halogen Bond Guides Conformational Selection

Area of Science:

• Medicinal Chemistry
• Structural Biology
• Biochemistry

Background:

• PIK-75 is a potent inhibitor targeting the alpha-isoform of phosphoinositide-3-kinase (PI3K).
• Previous studies highlighted the significance of nitro (NO2) and bromine (Br) substituents in PIK-75's activity but did not elucidate the mechanism.
• The precise structural basis for the high potency of PIK-75 remained undetermined.

Purpose of the Study:

• To elucidate the structural basis for the high potency of the PI3K inhibitor PIK-75.
• To investigate the role of the NO2 and Br substituents in PIK-75's interaction with its target kinase.
• To explore novel strategies for designing conformationally restricted bioactive molecules.

Main Methods:

• X-ray crystallography to determine the structure of PIK-75 in complex with Glycogen Synthase Kinase 3 beta (GSK-3β).
• Nuclear Magnetic Resonance (NMR) spectroscopy to study molecular conformation in solution.
• Molecular Dynamics (MD) simulations to analyze molecular behavior and interactions.

Main Results:

• The first X-ray crystal structure of PIK-75 bound to GSK-3β revealed an unusual U-shaped conformation.
• This conformation is stabilized by an atypical intramolecular bromine-nitrogen dioxide (Br⋅⋅⋅NO2) halogen bond.
• NMR and MD simulations indicated that this U-shaped conformation is also present in solution, suggesting preorganization for binding.

Conclusions:

• The study identified a novel intramolecular halogen bond as the key stabilizing force for PIK-75's U-shaped conformation.
• This conformationally preorganized state in solution directly explains the high potency of PIK-75.
• The findings suggest that incorporating site-specific halogen bonds is a viable strategy for designing potent, conformationally restricted drugs.